The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men

JAMA

Volumn 281, Issue 19, 1999, Pages 1822-1829

  Goldie, Sue J ^a   Kuntz, Karen M ^a   Weinstein, Milton C ^a   Freedberg, Kenneth A ^b   Welton, Mark L ^c   Palefsky, Joel M ^c  

^a HARVARD CENTER FOR RISK ANALYSIS   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANUS CARCINOMA; ARTICLE; BISEXUALITY; CANCER SCREENING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; MALE; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL METAPLASIA;

EID: 0033583708     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.19.1822     Document Type: Article

References (70)

1. Wexner S, Milsom J, Dailey T. The demographics of anal cancers are changing: identification of a high risk population. Dis Colon Rectum. 1987;30:942-946.
2. Holly EA, Whittemore AS, Aston DA, Ahn DK, Nickoloff BJ, Kristiansen JJ. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst. 1989;81:1726-1731.
3. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987;317:973-977.
4. Melbye M, Rabkin C, Frisch M, Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol. 1994;139:772-780.
5. Koblin BA, Hessol NA, Zauber AG, et al. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. Am J Epidemiol. 1996;144:916-923.
6. Qualters J, Lee N, Smith R, Aubert R. Breast and cervical cancer surveillance, United States, 1973-1987. MMWR Morb Mortal Wkly Rep. 1992;41(SS-2):1-15.
7. Melbye M, Cote TR, Kessler L, Gail M, Biggar RJ, for the AIDS/Cancer Working Group. High incidence of anal cancer among AIDS patients. Lancet. 1994; 343:636-639.
8. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998; 351:1833-1839.
9. Palefsky JM. Human papillomavirus-associated malignancies in HIV-positive men and women. Curr Opin Oncol. 1995;7:437-441.
10. Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev. 1995;4:415-428.
11. Palefsky JM, Holly EA, Gonzales J, Lamborn K, Hollander H. Natural history of anal cytologic abnormalities and papillomavirus infection among homosexual men with group IV HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1992;5:1258-1265.
12. Kiviat NB, Critchlow CW, Holmes KK, et al. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS. 1993;7:43-49.
13. Critchlow CW, Surawicz CM, Holmes KK, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, Immunosuppression and human papillomavirus infection, AIDS. 1995;9:1255-1262.
14. Unger ER, Vernon SD, Lee DR, et al. Human papillomavirus type in anal epithelial lesions is influenced by human immunodeficiency virus. Arch Pathol Lab Med. 1997;121:820-824.
15. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intraepithelial lesions among HIV-positive and HIV-negative homosexual/bisexual men. AIDS. 1998;12:495-503.
16. Palefsky JM, Holly EA, Hogeboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:314-319.
17. Sayers SJ, McMillan A, McGoogan E. Anal cytological abnormalities in HIV-infected homosexual men. Int J STD AIDS. 1998;9:37-40.
18. Palefsky JM, Shiboski S, Moss A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1994;7:599-606.
19. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in HIV-positive and HIV-negative homosexual men. J Infect Dis. 1998;177: 361-367.
20. Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS. 1994;8:283-295.
21. Northfelt DW, Swift PS, Palefsky JM. Anal neoplasia: pathogenesis, diagnosis, and management. Hematol Oncol Clin North Am. 1996;10:1177-1187.
22. Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:415-422.
23. Gold MR, Siegel JE, Russel LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press Inc; 1996.
24. Palefsky JM, Holly EA, Ralston ML, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:320-326.
25. Surawicz CM, Kirby P, Critchlow C, Sayer J, Dunphy C, Kiviat N. Anal dysplasia in homosexual men: role of anoscopy and biopsy. Gastroenterology. 1993; 105:658-666.
26. Aynaud O, Piron D, Barrasso R, Poveda JD. Comparison of clinical, histological, and virotogical symptoms of HPV in HIV-1 infected men and immunocompetent subjects. Sex Transm Infect. 1998;74:32-34.
27. Frazer IH, Medley G, Crapper RM, Brown TC, Mackay IR. Association between anorectal dysplasia: human immunodeficiency virus in homosexual men. Lancet. 1986;2:657-660.
28. Caussy D, Goedert JJ, Palefsky JM, Gonzales J, Rabkin CS, DiGioia RA. Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homsexual men. Int J Cancer. 1990;46:214-219.
29. Melbye M, Palefsky J, Gonzales J, et al. Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities. Int J Cancer. 1990;46:203-206.
30. Palefsky JM, Gonzales J, Greenblatt RM, Ahn DK, Hollander H. Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease. JAMA. 1990;263:2911-2916.
31. National Cancer Institute. Surveillance, epidemiology, end results (SEER) cancer statistics review, 1973-1994. Available at: http://www-seer.ims.nci.nih .gov/. Accessed November 11, 1998.
32. AIDS Cost and Services Utilization Survey: Public Use Tapes 4 and 5. Springfield, Va: National Technical Information Service; 1994. Publication PB94-189891.
33. Longini IM, Clark WS, Byers RH, et al. Statistical analysis of the stages of HIV Infection using a Markov model. Stat Med. 1989;8:831-843.
34. + T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach. J Acquir Immune Defic Syndr Hum Retrovirol. 1991; 4:1141-1147.
35. Enger C, Graham N, Peng Y, et al. Survival from early, intermediate, and late stages of HIV infection. JAMA. 1996;275:1329-1334.
36. Freedberg KA, Scharfstein JA, Seage GR, et al. The cost-effectiveness of preventing AIDS-related complications. JAMA. 1997;279:130-136.
37. Multicenter AIDS Cohort Study (MACS) Public Dataset Springfield, Va: National Technical Information Service; 1995. Release P04.
38. Daniel GL, Longo WE, Vemava AM III. Pruritus ani: causes and concerns. Dis Colon Rectum. 1994; 37:670-674.
39. Forti RL, Medwell SJ, Aboulafia DM, Surawicz CM, Spach DH. Clinical presentation of minimally invasive and in situ squamous cell carcinoma of the anus in homosexual men. Clin Infect Dis. 1995;21:603-607.
40. Surawicz CM, Critchlow C, Sayer J, et al. High grade anal dysplasia in visually normal mucosa in homosexual men: seven cases. Am J Gastroenterol. 1995; 90:1776-1778.
41. Jay N, Berry JM, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum. 1997;40:919-928.
42. Segal MJ, Heald RB, eds. Medicare RBRVS: The Physicians' Guide. Chicago, III: American Medical Association; 1997.
43. Taplin S, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995;87:417-426.
44. US Agency for Health Care Policy and Research. Statistics from the Healthcare Cost and Utilization Project (HCUP-3): nationwide inpatient sample for 1994, principal diagnoses. Available at: http:// www.ahcpr.gov/data/94dcchpr.htm. Accessed November 11, 1998.
45. US Bureau of Labor Statistics. US Dept of Labor, Bureau of Labor Statistics, 1997. Available at: http:// stats.bls.gov/datahome.htm. Accessed November 11, 1998.
46. Mendenhall WM, Sombeck MD, Speer TW, Marsh RD, Carroll RR, Copeland EM. Current management of squamous cell carcinoma of the anal canal. Surg Oncol. 1994;3:135-146.
47. Peddada AV, Smith DE, Rao AR, Frost DB. Kagan AR. Chemotherapy and low-dose radiotherapy in the treatment of HIV-Infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 1997;37:1101-1105.
48. Bottomley DM, Aqel N, Selvaratnam G. Phillips RH. Epidermold anal cancer in HIV Infected patients. Clin Oncol (R Coll Radiol). 1996;8:319-322.
49. Holland JM, Swift PS. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology. 1994;193:251-254.
50. Chadha M, Rosenblatt EA, Malamud S, Pisch J, Berson A. Squamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum. 1994;37:861-865.
51. Celentano DD, deLissovoy G. Assessment of cervical cancer screening and follow-up programs. Public Health Rev. 1989;17:173-240.
52. Hammer SM, Squires KE, Hughes MD, et al, for the AIDS Clinical Trials Group 320 Study Team. A controlled trial of two nucteoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337:725-733.
53. Gulick RM, Mellors JW, Havlir D, et al. Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamuvidine for HIV-1 infection, 100 week follow-up. JAMA. 1998;280:35-41.
54. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human Immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997; 337:734-739.
55. Flexner C. HIV-protease inhibitors. N Engl J Med. 1998;338:1281-1292.
56. Condra JH. Resisting resistance: maximizing the durability of antiretroviral therapy. Ann Intern Med. 1998;128:951-954.
57. de Ruiter A, Carter P, Katz DR, et al. A comparison between cytology and histology to detect anal intraepithelial neoplasia. Genitourin Med. 1994;70:22-25.
58. Sonnex C, Scholefield J, Kocjan G, et al. Anal human papillomavirus infection: a comparative study of cytology, colposcopy, and DNA hybridization as methods of detection. Genitourin Med. 1991;67:21-25.
59. Sherman ME, Friedman HB, Busseniers AE, Kelly WF, Carner TC, Saah AJ. Cytologic diagnosis of anal intraepithelial neoplasia using smears and Cytyc thinpreps. Mod Pathol. 1995;8:270-274.
60. Haye K, Malti H, Stanbridge C. Cytologic screening to detect subclinical anal human papillomavirus infection in homosexual men attending genitourinary medicine clinic. Genitourin Med. 1988;64:378-382.
61. Law CL, Qassim M, Thompson CH, et al. Factors associated with clinical and sub-clinical anal human papillomavirus infection in homosexual men. Genitourin Med. 1991;67:92-98.
62. Tsevat J, Solzan JG, Kuntz KM, et al. Health values of patients Infected with human immunodeficiency virus: relationship to mental health and physical functioning. Med Care. 1996;34:44-57.
63. Hslao WC, Braun P, Dunn D, Becker E. Resource-based relative values: an overview. JAMA. 1988;260: 2347-2353.
64. Cornelius L. Beauregard K, Cohen J. Usual Sources of Medical Care and Their Characteristics. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service; 1991. AHCPR publication 91-0042.
65. Hellinger FJ. The lifetime cost of treating a person with HIV. JAMA. 1993;270:474-478.
66. Berk ML, Mafeo C, Schur CI. Research design and analysis objectives: AIDS Cost and Services Utilization Survey Report No.1. Rockville, Md: Agency for Hearth Care Policy and Research; 1993. AHCPR publication 93-0019.
67. Cardinale V, ed. Drug Topics Red Book. Montvale, NJ: Medical Economics; 1997.
68. US Bureau of Census. Statistical Abstract of the United States: 1997. 117th ed. Washington, DC: US Bureau of Census; 1997.
69. Longo WE, Vernava AM, Wade TP, Coplin MA, Virgo KS, Johnson FE. Recurrent squamous cell carcinoma of the anal canal: predictors of initial treatment failure and results of salvage therapy. Ann Surg. 1994;220:40-49.
70. Kurman RJ, Henson DE, Herbst AL, Nolle KL, Schiffman MH. Interim guidelines for the management of abnormal cervical cytology: the 1992 National Cancer Institute Workshop. JAMA. 1994;271:1866.